Barbara Y. Chan
Finanzdirektor/CFO bei OMEGA THERAPEUTICS, INC.
Aktive Positionen von Barbara Y. Chan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OMEGA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 31.05.2024 | - |
Finanzdirektor/CFO | 31.05.2024 | - | |
Corporate Officer/Principal | - | 31.05.2024 |
Karriereverlauf von Barbara Y. Chan
Ehemalige bekannte Positionen von Barbara Y. Chan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NOVELION THERAPEUTICS INC. | Comptroller/Controller/Auditor | - | 24.09.2019 |
AEGERION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | - | - |
Präsident | - | - |
Ausbildung von Barbara Y. Chan
Bentley University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Kanada | 2 |
Operativ
Comptroller/Controller/Auditor | 2 |
Director/Board Member | 1 |
President | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OMEGA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
- Börse
- Insiders
- Barbara Y. Chan
- Erfahrung